Probi and Pharmavite expand collaboration in the US and international markets.
The two companies have signed a new long-term agreement for distribution and marketing of Probi’s probiotic products. Pharmavite launched Probi Digestis capsules based on Probi’s flagship strain LP299V in the US market under the Nature Made brand in 2012 and have accounted for a significant portion of Probi’s growth in the US. Pharmavite and Probi have now signed a new long-term agreement under which Pharmavite will broaden the distribution of Probi Digestis
capsules through additional sales channels on the US market.
Under the new agreement Pharmavite will broaden the distribution and expand the Nature Made range with additional probiotic products from Probi. Pharmavite will also expand it’s probiotic business internationally, among other markets, in the Middle East.
“We are very excited to expand our partnership with Pharmavite. Pharmavite is a reputable and skilled partner whose quality focus is an excellent match with Probi’s clinically proven products”, says Peter Nählstedt, CEO of Probi.
The companies have also signed an international agreement under which Pharmavite will launch Probi Digestis internationally on markets where Pharmavite is currently selling the Nature Made brand, states Probi. The first international market to launch is the United Arab Emirates and registration processes have been initiated in multiple countries in the Middle East.